GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Elite Diagnostic Ltd (XJAM:ELITE) » Definitions » Change In Payables And Accrued Expense

Elite Diagnostic (XJAM:ELITE) Change In Payables And Accrued Expense : JMD0.00 Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Elite Diagnostic Change In Payables And Accrued Expense?

Elite Diagnostic's Change In Payables And Accrued Expense for the quarter that ended in . 20 was JMD0.00 Mil. It means Elite Diagnostic's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Elite Diagnostic's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was JMD0.00 Mil. It means Elite Diagnostic's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Elite Diagnostic Change In Payables And Accrued Expense Historical Data

The historical data trend for Elite Diagnostic's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elite Diagnostic Change In Payables And Accrued Expense Chart

Elite Diagnostic Annual Data
Trend
Change In Payables And Accrued Expense

Elite Diagnostic Semi-Annual Data
Change In Payables And Accrued Expense

Elite Diagnostic Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 was JMD0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elite Diagnostic Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Elite Diagnostic's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Elite Diagnostic (XJAM:ELITE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Elite Diagnostic Ltd (XJAM:ELITE) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
HKSE:01522 HKSE:01900 HKSE:01037 HKSE:02176 HKSE:00318 HKSE:08319 HKSE:08062 HKSE:01985 HKSE:08017 HKSE:02350 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
1B Holborn Road, St. Andrew, Kingston, JAM, 5
Website
https://www.elite-diagnostic.com
Elite Diagnostic Ltd provides diagnostic and research services. The company offers various services such as Interventional Radiology Procedures, Magnetic Resonance Imaging (MRI), Computed Tomography (CT Scan), Ultrasound, X-Ray, Fluoroscopy, Endoscopic Ultrasound, the only one of its kind in the Caribbean. The company's revenue is derived mainly from diagnostic imaging services.

Elite Diagnostic (XJAM:ELITE) Headlines

No Headlines